Hepatitis

Prof. Yosef Shaul. A lifelong quest

Spiking the Particle

25.04.2022

Viruses & Microorganisms, Disease, Drugs & Diagnostics, Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

FDA approves third-generation hepatitis B vaccine based on Weizmann research

Prof. Yosef Shaul

Bio-Hep-B vaccine

12.09.2010

Genetics, Benefiting Humanity

Bio-Hep-B, a vaccine for hepatitis B based on Prof. Shaul's research, is produced by Biotechnology General and marketed in Israel

Prof. Yair Reisner

Hepatitis B and C Therapies

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

Prof. Yair Reisner developed mice with functioning human immune systems. These laboratory animals can be used for research on a...

TAKING ACTION AT STEP 1: MALIGNANT TRANSFORMATION

TAKING ACTION AT STEP 1: MALIGNANT TRANSFORMATION

01.09.2004

Space & Physics, Biochemistry, Cancer, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Genetics, Structural Biology

Contrary to popular belief, getting cancer is not so easy.

Top Stories

Shedding Light on the Dark Hours

Credit: Coleen Murphy, Princeton University, Princeton, NJ

Cracking the Code of a Worm's Throat

“Eight Shining Examples of Excellence”

Burning Cancer’s Bridges

Press Releases

“Eight Shining Examples of Excellence”

The Weizmann Institute of Science Ranked among the World’s Top Ten Academic Institutions

A Discovery to Set Your Heart a-Knocking

Most Popular Articles

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research